HOB Biotech Group Corp.,Ltd (SHA:688656)
China · Delayed Price · Currency is CNY 93.15
+0.05 (0.05%)
Aug 14, 2026, 3:00 PM CST
SHA:688656 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 5,835 | 9,640 | 5,946 | 2,192 | 2,114 | 3,973 | |
Market Cap Growth | -18.56% | 62.14% | 171.25% | 3.70% | -46.79% | - |
Enterprise Value | 5,810 | 9,636 | 5,949 | 2,041 | 1,816 | 3,855 |
Last Close Price | 93.10 | 153.53 | 95.00 | 33.98 | 32.49 | 60.27 |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 273.37 | 415.50 | 161.55 | 46.31 | 50.75 | 46.09 |
PS Ratio | 14.60 | 24.20 | 14.78 | 5.56 | 6.60 | 12.50 |
PB Ratio | 7.06 | 11.76 | 7.32 | 2.70 | 2.71 | 5.16 |
P/TBV Ratio | 7.15 | 11.92 | 7.41 | 2.74 | 2.76 | 5.24 |
P/OCF Ratio | 79.20 | 132.16 | 58.74 | 21.34 | 36.25 | 37.91 |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 14.54 | 24.19 | 14.79 | 5.17 | 5.67 | 12.13 |
EV/EBITDA Ratio | 67.74 | 119.92 | 70.87 | 23.62 | 26.33 | 37.04 |
EV/EBIT Ratio | - | 545.39 | 134.71 | 38.29 | 43.22 | 45.71 |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.04 | 0.06 | 0.14 | 0.07 | 0.08 | 0.04 |
Debt / EBITDA Ratio | 0.37 | 0.58 | 1.30 | 0.60 | 0.88 | 0.28 |
Net Debt / Equity Ratio | -0.03 | -0.02 | -0.01 | -0.13 | -0.29 | -0.55 |
Net Debt / EBITDA Ratio | -0.31 | -0.20 | -0.07 | -1.25 | -3.24 | -4.07 |
Net Debt / FCF Ratio | -0.70 | 16.59 | 0.11 | 1.43 | 1.38 | 6.72 |
Asset Turnover | 0.42 | 0.41 | 0.41 | 0.42 | 0.35 | 0.55 |
Inventory Turnover | 1.47 | 1.52 | 1.31 | 1.50 | 1.52 | 1.51 |
Quick Ratio | 1.25 | 1.11 | 0.82 | 1.54 | 2.14 | 5.76 |
Current Ratio | 2.75 | 2.17 | 1.39 | 2.42 | 2.77 | 6.62 |
Return on Equity (ROE) | 2.65% | 2.84% | 4.54% | 5.95% | 5.38% | 17.66% |
Return on Assets (ROA) | 1.02% | 1.12% | 2.79% | 3.52% | 2.90% | 9.09% |
Return on Invested Capital (ROIC) | 1.83% | 2.05% | 5.25% | 7.08% | 8.35% | 27.28% |
Return on Capital Employed (ROCE) | 1.90% | 2.10% | 5.40% | 6.60% | 5.30% | 10.80% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Aug '26 Aug 13, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.37% | 0.24% | 0.62% | 2.16% | 1.97% | 2.17% |
FCF Yield | 0.63% | -0.01% | -0.91% | -3.44% | -7.66% | -1.59% |
Dividend Yield | 0.21% | 0.13% | 0.32% | 1.18% | 0.92% | 0.88% |
Payout Ratio | 92.53% | 89.61% | 76.54% | 43.93% | 83.26% | 22.98% |
Buyback Yield / Dilution | -4.23% | 1.18% | 0.79% | -1.35% | -2.50% | -30.49% |
Total Shareholder Return | -4.02% | 1.31% | 1.11% | -0.18% | -1.58% | -29.61% |